AUS
NZ
UK
CA
USA
IND
Healt
Can ASX All Ordinaries Healthcare Stocks Find Cleaner Growth?
June 18, 2026 02:35 PM AEST| By SamHealthcare stocks are entering a more selective phase as markets focus on imaging contracts, diagnostics demand, biotechnology execution and commercial quality to identify cleaner growth opportunities.
AI Tailwinds Put ASX Healthcare Devices Back In Focus
June 18, 2026 02:32 PM AEST| By SamHealthcare stocks are facing a demand reset as device makers, diagnostics groups, imaging software providers and biotechnology names are judged on execution, margins and evidence.
Healthcare Recovery Radar: What Is Driving Fresh Interest In ASX Healthcare Stocks?
June 18, 2026 02:30 PM AEST| By SamASX healthcare stocks are regaining attention as investors reassess valuations, quality business models and sector fundamentals amid a more stable market backdrop focused on operational execution.
Why This Emerging Life Sciences Company Just Expanded Its Share Base
June 18, 2026 10:05 AM AEST| By SamVitrafy Life Sciences has applied to quote additional ordinary shares on the ASX, expanding its share capital while supporting liquidity and maintaining flexibility for future corporate initiatives.
Defensive Growth Rotation Is Putting Healthcare Back in the Spotlight
June 17, 2026 09:51 PM AEST| By SamHealthcare stocks are returning to focus as defensive growth themes gain momentum, with market participants closely watching earnings quality, cash flow resilience and execution across leading Australian healthcare companies.
Can Medtech Contract Momentum Reshape The Next Move In ASX healthcare?
June 17, 2026 09:49 PM AEST| By SamHealthcare stocks are back on the radar as investors focus on medtech contract quality, earnings visibility and business execution. Companies with strong cash flow, durable revenue and disciplined growth strategies are attracting increased market att...
Healthcare Stocks Catch Breath as CSL Sparks Rebound
June 17, 2026 02:03 PM AEST| By SamASX healthcare stocks have rebounded sharply, led by CSL, as sector rotation and valuation resets bring defensive names back into focus within the ASX 200 environment.
Cochlear (ASX:COH) Guidance Cut Shakes ASX Healthcare
June 17, 2026 02:03 PM AEST| By SamCochlear’s earnings downgrade in 2026 reset expectations across ASX healthcare stocks, highlighting valuation sensitivity and shifting sentiment in premium medical device companies.
ASX Healthcare Winners Stand Out: PME vs RMD
June 17, 2026 02:03 PM AEST| By SamPro Medicus and ResMed highlight how execution, contracts and margin strength define leadership in ASX healthcare, standing out amid mixed sector performance across 2026.
ASX 200 Healthcare Watch: CSL (ASX:CSL) Valuation Debate Deepens
June 17, 2026 04:25 AM AEST| By SamCSL is under renewed focus ahead of earnings as valuation discussions intensify. The biotechnology leader continues to anchor Australia’s healthcare sector through plasma, vaccines and specialty medicines.
Watch ResMed’s GLP-1 Fear Fade as Data Tells a Different Story
June 16, 2026 06:12 PM AEST| By SamResMed has been pressured by GLP-1 fears, but real-world data shows combined therapy use is common. This challenges disruption concerns and reshapes sentiment across ASX healthcare stocks in 2026.
Is Healthcare Turning? CSL Leads ASX Sector Bounce
June 16, 2026 06:12 PM AEST| By SamASX healthcare equities see renewed attention as CSL leads sentiment shift, while Cochlear, ResMed and Sigma Healthcare reflect a more segmented sector recovery phase.
Is Sigma Healthcare Building a Different ASX Healthcare Path?
June 16, 2026 06:12 PM AEST| By SamSigma Healthcare reflects a pharmacy-focused healthcare model tied to everyday prescription demand, operating differently from biotech peers within Australia’s evolving healthcare sector landscape.
Healthcare's Second Chance: Why ASX Healthcare Stocks Are Back in Focus
June 16, 2026 03:44 PM AEST| By SamHealthcare stocks are regaining attention as investors focus on defensive growth, earnings visibility and valuation recovery across some of Australia's leading healthcare companies.
Healthcare's Split Decision: Why Medtech and Software Stocks Are Taking Different Paths
June 16, 2026 03:43 PM AEST| By SamASX healthcare stocks are drawing renewed attention as investors compare the growth potential, valuation outlook and earnings visibility of medtech and healthcare software businesses.
Telix's New Healthcare Collaboration Sparks Fresh Market Discussion
June 16, 2026 10:43 AM AEST| By SamTelix Pharmaceuticals strengthened its precision medicine strategy through a new healthcare collaboration that combines imaging technologies, artificial intelligence tools, and theranostic workflows.
Healthcare Stocks Back in Focus as Device and Diagnostics Trends Gain Attention
June 15, 2026 08:46 PM AEST| By SamHealthcare stocks are gaining attention as device and diagnostics activity supports sector momentum, with investors tracking demand trends, cash flow strength, and broader market signals across major ASX healthcare names.
Healthcare Stocks Back In Focus As Market Searches For Stability
June 15, 2026 08:43 PM AEST| By SamHealthcare stocks are gaining renewed attention as market participants evaluate earnings strength, global demand and sector leadership across major healthcare companies listed on the Australian market.
Telix Pharmaceuticals ASX TLX 2026: Radiopharma Growth Surge
June 15, 2026 02:19 PM AEST| By SamTelix Pharmaceuticals (ASX:TLX) is expanding rapidly in radiopharmaceuticals, supported by FDA progress, a major Regeneron partnership and strong revenue growth within the ASX healthcare sector.
CSL Under Pressure: Can the Healthcare Giant Rebuild Momentum?
June 15, 2026 02:14 PM AEST| By SamCSL is navigating a complex restructuring phase after a challenging year, with early signs of stabilisation emerging as the company refocuses on plasma, vaccines and long-term innovation.
Advertise your brand on Kalkine Media